Rhythm Pharmaceuticals Inc Earnings

Rhythm Pharmaceuticals Inc’s revenue jumped 54.28% since last year same period to $51.3Mn in the Q3 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 5.76% jump in its revenue since last 3-months.

Rhythm Pharmaceuticals Inc’s net profit fell -21.23% since last year same period to $-52.9Mn in the Q3 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -13.45% fall in its net profits since last 3-months.

Rhythm Pharmaceuticals Inc’s net profit margin jumped 21.42% since last year same period to -103.13% in the Q3 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -7.27% fall in its net profit margins since last 3-months.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.82 - a 0.07% jump from last quarter’s estimates.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.82.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Rhythm Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.